
|Articles|February 27, 2006
...but March of Dimes applauds it
The March of Dimes applauded the new FDA iPLEDGE program. The March of Dimes urged the agency to monitor the program's effectiveness and to create comparable programs for other oral retinoid medications.
Advertisement
... but March of Dimes applauds it
The March of Dimes applauded the new FDA iPLEDGE program. The March of Dimes urged the agency to monitor the program's effectiveness and to create comparable programs for other oral retinoid medications. The March of Dimes is also concerned that some patients may seek to purchase isotretinoin via the Internet and circumvent the requirements.
To see more Hot off the Press news articles, click here
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Study Identifies Patients at Risk for Severe COVID-19 Post-Vaccination
2
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
3
Investigational Oral AD109 Reduces Sleep Apnea Severity by 44%
4
Zepbound Lowers Health Care Costs in Older Adults With Obesity
5






































